Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound

Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound

US Patent 8207121 · Granted Jun 26, 2012

Estimated economic value: $171,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of determining toxicity of an immunomodulatory drug for use in humans2025
Methods and models for assessing efficacy of immunotherapies2025
Humanized mouse models for assessing immune cell therapy2025
Method of determining toxicity of an immunomodulatory drug for use in humans2024
Method of determining toxicity of an immunomodulatory drug for use in humans pre2024
Non-HLA matched humanized NSG mouse model with patient-derived xenograft2022
Methods of treating virally associated cancers with histone deacetylase inhibito2021
Compositions and methods for treating myelodysplastic syndrome2014
Purine inhibitors of cyclin dependent kinase 2 and IκB-α2006
Use of ribozymes for functionating genes2004
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha2004
Purine inhibitors of cyclin dependent kinase 2 & IKBA2004